Abstract
BackgroundRecent advances in immunotherapy have shown promising results in triple-negative breast cancer (TNBC). Studies regarding PDL1/PD1 co-inhibitory pathway demonstrate that PDL1 positive subgroup of TNBCs had better prognosis and increased...
Paper version not known (Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have